Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. | Cancer Med | 2024 | 39513266 | PubTator, text mining | PubMed |
| Breast cancer genomic analyses reveal genes, mutations, and signaling networks. | Funct Integr Genomics | 2024 | 39496981 | PubTator, text mining | PubMed |
| [Effect of Tumor Suppressor Gene Kmt2c Heterozygous Deletion on Hematopoietic System in Mice]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39479850 | PubTator, text mining | PubMed |
| Breast cancer in adolescents and young adults has a specific biology and poor patient outcome compared with older patients. | ESMO Open | 2024 | 39405895 | PubTator, text mining | PubMed |
| Retraction: KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition. | Clin Cancer Res | 2024 | 39402969 | PubTator, text mining | PubMed |
| Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer. | Sci Rep | 2024 | 39390002 | PubTator, text mining | PubMed |
| MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma. | Blood Cancer J | 2024 | 39375391 | PubTator, text mining | PubMed |
| Advancing Cancer Care in Colombia: Results of the First In Situ Implementation of Comprehensive Genomic Profiling. | J Pers Med | 2024 | 39338229 | PubTator, text mining | PubMed |
| A Pilot Study Based on the Correlation Between Whole Exome and Transcriptome Reveals Potent Variants in the Indian Population of Cervical Cancer. | Indian J Microbiol | 2024 | 39282199 | PubTator, text mining | PubMed |
| Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. | J Cancer Res Clin Oncol | 2024 | 39244518 | PubTator, text mining | PubMed |
| Monomorphic epitheliotropic intestinal T-cell lymphoma: report of four cases and literature review. | J Int Med Res | 2024 | 39197860 | PubTator, text mining | PubMed |
| The modification role and tumor association with a methyltransferase: KMT2C. | Front Immunol | 2024 | 39165358 | PubTator, text mining | PubMed |
| Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients. | J Hematol Oncol | 2024 | 39160538 | PubTator, text mining | PubMed |
| Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing. | BMC Med Genomics | 2024 | 39123171 | PubTator, text mining | PubMed |
| Advancing the molecular understanding of renal tumorigenesis: Acquired cystic disease-associated renal cell carcinoma (ACD-RCC) as a model system. | Ann Diagn Pathol | 2024 | 39121515 | PubTator, text mining | PubMed |
| Experience of the first adult-focussed undiagnosed disease program in Australia (AHA-UDP): solving rare and puzzling genetic disorders is ageless. | Orphanet J Rare Dis | 2024 | 39095811 | PubTator, text mining | PubMed |
| Pan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy. | Oncol Lett | 2024 | 39091583 | PubTator, text mining | PubMed |
| Implication of KMT2C and TSC2 variants in the tumorigenesis of acquired cystic disease-associated renal cell carcinomas. | Ann Diagn Pathol | 2024 | 39089178 | PubTator, text mining | PubMed |
| Integrative Omics Uncovers Low Tumorous Magnesium Content as A Driver Factor of Colorectal Cancer. | Genomics Proteomics Bioinformatics | 2024 | 39052867 | PubTator, text mining | PubMed |
| Perfluorooctanesulfonic acid (PFOS) induced cancer related DNA methylation alterations in human breast cells: A whole genome methylome study. | Sci Total Environ | 2024 | 39032741 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=11